| Animal research: Reporting in vivo experiments: The ARRIVE guidelines | 2010/07/06 | English | 2,978 |
| Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean? | 2004/05/01 | English | 1,531 |
| Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo | 1990/11/01 | English | 1,372 |
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | 2010/07/06 | English | 1,352 |
| Principles of early drug discovery | 2011/02/22 | English | 1,293 |
| The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin | 2008/01/01 | English | 1,234 |
| Microglial M1/M2 polarization and metabolic states | 2015/05/11 | English | 1,176 |
| Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP | 2015/05/12 | English | 1,142 |
| Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers | 2018/03/09 | English | 1,081 |
| The orphan receptor GPR55 is a novel cannabinoid receptor | 2007/12/01 | English | 1,061 |
| The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate | 1983/06/01 | English | 938 |
| Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) | 2011/10/01 | English | 933 |
| Experimental design and analysis and their reporting: new guidance for publication in BJP | 2015/06/26 | English | 922 |
| Therapeutic antibodies: successes, limitations and hopes for the future | 2009/04/28 | English | 917 |
| Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide | 2001/10/01 | English | 896 |
| Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects | 2011/07/12 | English | 895 |
| The role of inflammation in CNS injury and disease | 2006/01/01 | English | 867 |
| Endothelial dysfunction in diabetes | 2000/07/01 | English | 789 |
| The use of animal models in diabetes research | 2012/05/08 | English | 782 |
| Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brain | 1970/07/01 | English | 774 |
| Stimulus‐secretion coupling: the concept and clues from chromaffin and other cells | 1968/11/01 | English | 772 |
| The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide | 1987/11/01 | English | 728 |
| SIXTH GADDUM MEMORIAL LECTURE NATIONAL INSTITUTE FOR MEDICAL RESEARCH, MILL HILL, JANUARY 1977 | 1977/08/01 | English | 689 |
| Guide to Receptors and Channels (GRAC), 5th edition | 2011/11/01 | English | 675 |
| Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors | 1998/11/01 | English | 670 |
| Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor | 2015/10/01 | English | 661 |
| Minocycline: far beyond an antibiotic | 2013/04/25 | English | 646 |
| Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics | 2009/04/28 | English | 642 |
| Impact of OATP transporters on pharmacokinetics | 2009/10/01 | English | 636 |
| Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases | 2016/10/21 | English | 624 |